Under the supervision of the series editors, an international team of expert authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews, in which selected adverse effects are discussed in depth. The use of the book is enhanced by two separate indexes, allowing the reader to enter the text by drug name, adverse effect name, or drug interaction.
The current Annual is the first update of the standard encyclopaedic work in this field, [external URL] Side Effects of Drugs, Fourteenth Edition, which was published in December 2000.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Essay: Secrecy hiding harm: case histories from the past that inform the future (I. Palmlund).
1. Central nervous system stimulants, drugs that suppress appetite, and drugs used in Alzheimer's disease (R.P. Sequeira).
2. Antidepressant drugs (P.J. Cowen).
3. Lithium (J.W. Jefferson).
4. Drugs of abuse (J.K. Patel, E. Wong, A.I. Green).
5. Hypnotics and sedatives (S. Curran, S. Musa).
6. Antipsychotic drugs (A. Carvajal, L.H. Martín Arias).
7. Antiepileptic drugs (E. Perucca).
8. Opioid analgesics and narcotic antagonists (A.H. Ghodse, A.M. Baldacchino).
9. Anti-inflammatory and antipyretic analgesics and drugs used in gout (A. Del Favero).
10. General anesthetics and therapeutic gases (T.G. Short, E. Hedayati).
11. Local anesthetics (S.A. Schug, D. Watson).
12. Neuromuscular blocking agents and skeletal muscle relaxants (O. Zuzan, M. Leuwer).
13. Drugs affecting autonomic functions or the extrapyramidal system (M. Schachter).
14. Dermatological drugs, topical agents, and cosmetics (M.M. Meinardi, M. Mulder).
15. Antihistamines (A.N. Nicholson).
16. Drugs acting on the respiratory tract (T.D. Robinson, A. Havryk, J.P. Seale).
17. Positive inotropic drugs and drugs used in dysrhythmias (J.K. Aronson).
18. Beta-adrenoceptor antagonists and antianginal drugs (A.P. Maggioni, M.G. Franzosi, R. Latini).
19. Drugs acting on the cerebral and peripheral circulations (R. Verhaeghe).
20. Antihypertensive drugs (F. Zannad).
21. Diuretics (G.T. MacInnes).
22. Metals (G.B. van der Voet, F.A. de Wolff).
23. Metal antagonists (R.H.B. Meyboom).
24. Antiseptic drugs and disinfectants (P. Magee).
25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines (T. Midtvedt).
26. Miscellaneous antibacterial drugs (R. Walter).
27. Antifungal drugs (A.H. Groll, C.C. Chiou, T.J. Walsh).
28. Antiprotozoal drugs (C.J.M. Whitty, S. Krishna).
29. Antiviral drugs (M.N.G. Dukes).
30. Drugs used in tuberculosis and leprosy (C.J. Ellis).
31. Antihelminthic drugs (A.G.C. Bauer).
32. Vaccines (S. Dittmann).
33. Blood, blood components, plasma and plasma products (H.W. Eijkhout, W.G. van Aken).
34. Intravenous infusions
solutions and emulsions (M.C. Allwood).
35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis (K. Peerlinck, J. Vermylen).
36. Gastrointestinal drugs (H.J. de Silva).
37. Drugs acting on the immune system (T. Vial, J. Descotes).
38. Vitamins (H.D. Reuter).
39. Corticotrophins, corticosteroids and prostaglandins (J. Costa, M. Farré).
40. Sex hormones and related compounds, including hormonal contraceptives (M.N.G. Dukes).
41. Thyroid hormones and antithyroid drugs (J.A. Franklyn).
42. Insulin, glucagon, and hypoglycemic drugs (H.M.J. Krans).
43. Miscellaneous hormones (P. Coates).
44. Drugs affecting lipid metabolism (I. Aursnes).
45. Cytostatic drugs (A. Stanley).
46. Radiological contrast agents (S.K. Morcos, P. Brown).
47. Drugs used in ocular treatment (B.C.P. Polak).
48. Treatments used in complementary medicine (E. Ernst).
49. Miscellaneous drugs, materials, and medical devices (N.H. Choulis).
50. The WHO international Drug Monitoring Programme (S. Olsson, I.R. Edwards).
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the <b>Meyler</b> series since 1977 and has published many research papers on adverse drug reactions. He is also the editor of <b>Meyler's Side Effects of Drugs</b> and the <b>Side Effects of Drugs Annual</b> series. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.